Bay Street News, November 12th, 2018

Focus will be on Milestones for Development and Commercialization CAP-1002 Therapy for Duchenne Muscular Dystrophy LOS ANGELES, Nov. 12, 2018 […]

HOUSTON, Nov. 12, 2018 (GLOBE NEWSWIRE) — DynaEnergetics, a business of DMC Global Inc. (Nasdaq: BOOM), today announced it has […]

Summit Therapeutics plc  (‘Summit’ or the ’Company’) Summit Highlights Importance of Innovation in Fight Against Antibiotic Resistance During Antibiotics Awareness […]

CRANBURY, N.J., Nov. 12, 2018 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD) today announced that John F. Crowley, Chairman and […]

Mersana Chief Scientific Officer, Timothy B. Lowinger, Ph.D. to chair 2018 Conference CAMBRIDGE, Mass., Nov. 12, 2018 (GLOBE NEWSWIRE) — […]

PDUFA date set for June 30, 2019 SAN DIEGO, Nov. 12, 2018 (GLOBE NEWSWIRE) — Retrophin, Inc. (NASDAQ: RTRX) today […]

Total Revenues for First Nine Months of 2018 were $66.3 Million, a 1% Decrease Year-Over-Year Gross Profit for First Nine […]

Financial Highlights Sales increased 6.7% to $95.7 million Operating income increased 13.9% to $5.3 million and adjusted EBITDA1 increased 9.5% […]

TORONTO, Nov. 12, 2018 (GLOBE NEWSWIRE) — Sprott Inc. (TSX: SII) (“Sprott” or the “Company”) today announced its financial results […]

CALGARY, Alberta, Nov. 12, 2018 (GLOBE NEWSWIRE) — NuVista Energy Ltd. (“NuVista” or the “Company”) (TSX:NVA) is pleased to announce […]